NEW YORK, Dec. 27, 2025, 7:11 p.m. ET — Market closed.
ICL Group Ltd (NYSE: ICL) is heading into the final trading days of 2025 with investors watching two storylines at once: a cyclical fertilizer/potash backdrop that’s turning more stable into 2026, and a company-specific push toward higher-value specialty businesses such as functional food ingredients and specialty crop nutrition.
The stock finished the last regular session (Friday, Dec. 26) at $5.54, up 3.55% on the day, and traded to about $5.59 in after-hours dealing. With U.S. markets closed for the weekend, the next catalyst for price discovery arrives Monday morning, when liquidity and year-end positioning can amplify moves—especially in mid-cap materials names.
Where ICL stock stands going into the next session
On Friday, ICL outperformed a nearly flat broader market. Wall Street ended a light-volume post-Christmas session slightly lower, with the Dow down 0.04%, the S&P 500 down 0.03%, and the Nasdaq down 0.09%, according to Reuters. Reuters In that same Reuters report, Ryan Detrick, chief market strategist at Carson Group, described the day as the market “catching our breath” after a strong rally and noted the seasonal “Santa Claus rally” window remains in play. Reuters
Key market stats for ICL as of Friday’s close/last after-hours print include: market cap about $7.15B, 52-week range $4.70–$7.35, trailing P/E about 19.4, and an indicated dividend of about $0.19 per share (roughly 3.5% yield based on the latest close).
Technically, ICL ended the week below its 50-day moving average (~$5.66) and 200-day moving average (~$6.24), a setup that often keeps both momentum traders and value-focused investors engaged as the stock approaches widely watched levels.
The last 24–48 hours: what’s new (and what isn’t)
Company-specific, market-moving headlines on ICL itself have been limited over the last two days—typical for a holiday week. But several market and sector reads published within the last 24–48 hours are shaping the narrative investors are likely to bring into Monday:
- Fertilizer stocks “to watch” screeners are flagging ICL on liquidity. MarketBeat updated a fertilizer watch list on Dec. 27 that included ICL alongside Mosaic, Nutrien, CF Industries, and CVR Energy, based on recent “highest dollar trading volume” among fertilizer names. MarketBeat
- Potash market tone for 2026 is being framed as steadier than nitrogen or phosphorus. DTN’s fertilizer outlook coverage emphasized ample global potash supply and highlighted views from industry analysts that the potash price outlook into 2026 looks steady, with supply dynamics more supportive than for other nutrients.
- Short-term technical commentary is calling for choppiness around current levels. A Stock Traders Daily note (Dec. 26) described “divergent sentiment readings” and “choppy conditions,” publishing a set of reference levels centered around $5.33 / $5.54 / $6.06 / $6.79. Stock Traders Daily
- Investor-education coverage is focusing on valuation and recent price ranges. AAII published a Dec. 27 piece reviewing ICL’s latest close, recent trading ranges, and valuation metrics, reflecting the type of weekend reading that can influence retail order flow into Monday.
Why potash matters so much for ICL right now
Even as ICL leans harder into specialty products, potash remains a major swing factor for sentiment and earnings power—especially when investors are searching for “clean” commodity exposure with contract visibility.
One helpful anchor: the World Bank–sourced potash spot benchmark tracked by YCharts shows Potassium Chloride (Muriate of Potash) at $353.75/mt for Nov. 2025, and notes it was last updated Dec. 3. While that benchmark is not a real-time trading print, it illustrates a potash price environment that is materially above year-ago levels—relevant for producers and contract negotiations.
DTN’s late-week reporting also underscored that global potash supply is “well-supplied” and that analysts see a steady price outlook into 2026. DTN cited Mark Milam (ICIS) and Justin Rackleff (CRU) in discussing supply, affordability, and factors that could affect fertilizer demand in the U.S. next year. DTN PF
The biggest recent ICL-specific catalyst investors are still digesting: China potash contracts for 2026
Although it falls just outside the last 48 hours, ICL filed a notable update this week that is directly tied to its 2026 potash revenue visibility:
In a Form 6‑K dated Dec. 23, 2025, ICL disclosed that—within its 2025–2027 framework agreements with customers in China—it signed contracts to supply 750,000 metric tons of potash in 2026, with a mutual option for an additional 330,000 metric tons, at a price aligned with recent China contract settlements ($348 per ton CIFFO).
For investors, there are two key takeaways from that filing:
- Volume visibility: contracted tonnage (plus an option) can reduce uncertainty around at least a portion of 2026 sales.
- Pricing reference: the disclosed benchmark-aligned pricing provides a concrete data point for the company’s potash realizations into 2026, particularly important when potash headlines can swing sentiment.
Strategy shift: specialty growth and food ingredients are becoming a bigger part of the story
ICL’s equity narrative is increasingly about balancing cyclical minerals with specialty growth engines—an approach the company has been emphasizing in investor materials and recent dealmaking.
Bartek Ingredients deal: a step deeper into food ingredients
On Dec. 18, ICL announced it entered into a definitive agreement to acquire Bartek Ingredients, describing Bartek as a global leader in malonic acid and derivatives used in food, flavor, fragrance, pharma, and other applications. The company said the transaction will be executed in two phases, with the first phase expected to close in Q1 2026 and involving a cash investment of about $90 million for roughly 50% of Bartek, with a second phase allowing ICL to acquire the remainder later.
In the release, ICL President & CEO Elad Aharonson said the acquisition aligns with ICL’s strategy to grow its specialty business portfolio, while Bartek CEO Andrew Ross highlighted the partnership’s role in supporting expansion plans, including a new facility expected in 2026.
Investor presentation: framing the total addressable opportunity
ICL also filed an Investor Presentation on Form 6‑K earlier this month to make it broadly accessible, stating it would be used in upcoming investor meetings. SEC The presentation text highlights a $152B food ingredients market and a $35B “functional ingredients” opportunity, alongside growth rates the company cites from third-party research and internal analysis. SEC
For stockholders, the practical question is whether these specialty initiatives can (over time) smooth earnings volatility typically associated with fertilizer and potash cycles.
Analyst forecasts: “Hold” consensus, ~$6.23 target, and a key date to watch
Analyst sentiment on ICL remains cautious but not bearish. MarketBeat’s latest aggregation shows:
- Consensus rating: Hold (based on 4 analyst ratings)
- Consensus price target: $6.23 (with $6.00 low and $6.50 high) — roughly 12% upside from the latest close
MarketBeat’s listings also reference named coverage, including Barclays analyst Benjamin Theurer, associated with an “Equal Weight” stance and a $6.00 target in the site’s recent-analyst table. MarketBeat
On the calendar, MarketBeat estimates ICL’s next earnings date as Wednesday, Feb. 25, 2026 (before market open), stressing the date is estimated based on historical schedules. It also summarizes that earnings are expected to grow next year (MarketBeat’s model shows a move from about $0.37 to $0.42).
Separately, ICL’s investor relations site lists a broad set of banks/firms providing analyst coverage (helpful for investors tracking who shapes consensus), including Bank of America, Barclays, Jefferies, Goldman Sachs, Morgan Stanley and others.
What investors should know before the next session (Monday)
With NYSE trading closed right now, here’s what typically matters most for ICL shareholders ahead of Monday’s open—especially in year-end conditions:
- Watch the macro tape and “materials” leadership. Reuters noted that the S&P 500’s materials sector led gains in Friday’s session even as the major indexes finished slightly lower. That matters because ICL trades as a materials/ag-inputs name and can ride sector flows during thin liquidity. Reuters
- Monitor potash signals and 2026 pricing expectations. DTN’s reporting points to a steadier potash outlook versus other nutrients, citing industry analysts. Meanwhile, ICL’s own 6‑K disclosure pegs 2026 China contract pricing to $348/ton CIFFO, a concrete benchmark investors may reference when potash headlines hit.
- Keep the focus on execution risk—and upside—around specialty growth. The Bartek transaction is positioned as an expansion in food ingredients with a staged closing approach into 2026, and ICL’s investor presentation frames large addressable markets. Investors will likely look for tangible milestones (closing progress, capacity expansion, margin profile) as 2026 guidance approaches.
- Know the levels traders are watching. Short-term technical commentary published Friday night highlighted $5.33 as a key reference area and $6.06 as a notable trigger/target level, while broader moving averages sit above the market at roughly $5.66 (50‑day) and $6.24 (200‑day)—a setup that can define “risk-on vs. risk-off” behavior in the first sessions of the new year. Stock Traders Daily+1
- Earnings timing is approaching. While not immediate, an estimated late‑February report date is close enough that investors may start repositioning in January—particularly if fertilizer and commodity inputs trend sharply in either direction.
Bottom line
ICL stock enters the next session on a firmer footing after Friday’s move, with the broader market still near record territory but trading in a holiday-thin environment. The near-term debate is whether ICL’s improving potash contract visibility for 2026, alongside its specialty push (notably food ingredients), is enough to re-rate the shares toward the low-$6 consensus target—or whether the stock remains range-bound until earnings season delivers clearer 2026 guidance.
